Disease Landscape and Forecast 인사이트
종합적인 시장 정보와 실행 가능한 인사이트를 통해 장기적인 질병 전략을 최적화하세요.
Methicillin-Resistant Staphylococcus Aureus Complicated Skin and Skin Structure Infections | Decision Base | US/EU | 2014
In The Crowded MRSA cSSSI Market, How Will Emerging Therapies Differentiate Themselves from Current Standard of Care? Methicillin-resistant Staphylococcus aureus (MRSA) is a clinically important…
Methicillin-Resistant Staphylococcus Aureus Complicated Skin and Skin Structure Infections | Decision Base | US | 2014
In The Crowded MRSA cSSSI Market, How Will Emerging Therapies Differentiate Themselves from Current Standard of Care? Methicillin-resistant Staphylococcus aureus (MRSA) is a clinically important…
Breast Cancer (The Expanding Role of Targeted Agents in Breast Cancer: Physician and Payer Receptivity to the Integration of Novel Premium-Priced Therapies in Highly Generic Market Segments) | Physician & Payer Forum | US | 2014
Treatment for breast cancer (CaB) in the United States has matured as oncologists have formalized protocols around specific patient populations, namely HER2+, HR+/HER2-, and HR-/HER2- (also known…